Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04899440 · ClinicalTrials.gov registry record
Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use
A clinical trial, sponsored by Procter and Gamble.
- Completed
- Registry status
- 30
- Enrollment target
NCT04899440: Completed study, sponsored by Procter and Gamble.
NCT04899440 is a clinical trial that has completed, run by Procter and Gamble. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04899440 has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The primary objective of this exploratory study is to evaluate the efficacy of an Oral Irrigator in the reduction of gingivitis compared to a negative control over a 3 week period by using the Modified Gingival Index and the Gingival Bleeding Index. The secondary objective is to evaluate the efficacy of an Oral Irrigator in the reduction of plaque compared to a negative control using the extended Turesky Modified Quigley-Hein Index (TQHPI) after 3 weeks of use.
Primary Outcome
Modified Gingival Index score after 3 weeks of product use. Gingivitis will be scored on the buccal and lingual marginal gingival and interdental papilla of all scorable teeth (six scores per tooth):0 = normal (absence of inflammation); 1 = mild inflammation (slight change of color, little change in texture) of any portion of the gingival unit; 2 = mild inflammation of the entire gingival unit; 3 = moderate inflammation (moderate glazing, redness, edema and/or hypertrophy) of the gingival unit;
Interventions
- OTHER Control
- DEVICE Water Flosser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2021-06-24 |
What the finished NCT04899440 record still lists
NCT04899440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT04899440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04899440 about?
NCT04899440 is a clinical study titled "Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use". The primary objective of this exploratory study is to evaluate the efficacy of an Oral Irrigator in the reduction of gingivitis compared to a negative control over a 3 week period by using the Modified Gingival Index and the Gingival Bleeding Index. The secondary objective is to evaluate the efficac...
What is the current status of trial NCT04899440?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-06-03. Estimated completion is 2021-06-24.
What interventions are being tested in trial NCT04899440?
The interventions under investigation include: Control (OTHER), Water Flosser (DEVICE).
Who is sponsoring clinical trial NCT04899440?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI